Literature DB >> 28932513

Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer.

Umberto Ricardi1, Niccolò Giaj Levra2, Serena Badellino1, Filippo Alongi2,3.   

Abstract

Entities:  

Year:  2017        PMID： 28932513      PMCID： PMC5594180          DOI： 10.21037/jtd.2017.06.133

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  15 in total

Review 1.  Review and uses of stereotactic body radiation therapy for oligometastases.

Authors:  Filippo Alongi; Stefano Arcangeli; Andrea Riccardo Filippi; Umberto Ricardi; Marta Scorsetti
Journal:  Oncologist       Date:  2012-06-20

Review 2.  Management of non-small cell lung cancer with oligometastasis.

Authors:  Liza C Villaruz; Gregory J Kubicek; Mark A Socinski
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

3.  Local consolidative therapy may be beneficial in patients with oligometastatic non-small cell lung cancer.

Authors:  Mary Kay Barton
Journal:  CA Cancer J Clin       Date:  2017-01-17       Impact factor: 508.702

4.  Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer.

Authors:  Ravi B Parikh; Angel M Cronin; David E Kozono; Geoffrey R Oxnard; Raymond H Mak; David M Jackman; Peter C Lo; Elizabeth H Baldini; Bruce E Johnson; Aileen B Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-24       Impact factor: 7.038

5.  Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study.

Authors:  M Trovo; N Giaj-Levra; C Furlan; M T Bortolin; E Muraro; J Polesel; E Minatel; R Tedeschi; A R Filippi; F Alongi; U Ricardi
Journal:  Clin Transl Oncol       Date:  2015-12-21       Impact factor: 3.405

6.  Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis.

Authors:  Kyle E Rusthoven; Susan F Hammerman; Brian D Kavanagh; Michael J Birtwhistle; Mark Stares; D Ross Camidge
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

Review 7.  An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Authors:  Allison B Ashworth; Suresh Senan; David A Palma; Marc Riquet; Yong Chan Ahn; Umberto Ricardi; Maria T Congedo; Daniel R Gomez; Gavin M Wright; Giulio Melloni; Michael T Milano; Claudio V Sole; Tommaso M De Pas; Dennis L Carter; Andrew J Warner; George B Rodrigues
Journal:  Clin Lung Cancer       Date:  2014-05-15       Impact factor: 4.785

8.  Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.

Authors:  Maria Grazia Ruocco; Karsten A Pilones; Noriko Kawashima; Michael Cammer; Julie Huang; James S Babb; Mengling Liu; Silvia C Formenti; Michael L Dustin; Sandra Demaria
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

9.  Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Authors:  Daniel R Gomez; George R Blumenschein; J Jack Lee; Mike Hernandez; Rong Ye; D Ross Camidge; Robert C Doebele; Ferdinandos Skoulidis; Laurie E Gaspar; Don L Gibbons; Jose A Karam; Brian D Kavanagh; Chad Tang; Ritsuko Komaki; Alexander V Louie; David A Palma; Anne S Tsao; Boris Sepesi; William N William; Jianjun Zhang; Qiuling Shi; Xin Shelley Wang; Stephen G Swisher; John V Heymach
Journal:  Lancet Oncol       Date:  2016-10-24       Impact factor: 41.316

Review 10.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019
View more
  3 in total

Review 1.  Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis.

Authors:  Elisa Gobbini; Luca Bertolaccini; Niccolò Giaj-Levra; Jessica Menis; Matteo Giaj-Levra
Journal:  Transl Lung Cancer Res       Date:  2021-07

2.  Reduction of inter-observer differences in the delineation of the target in spinal metastases SBRT using an automatic contouring dedicated system.

Authors:  Niccolò Giaj-Levra; Vanessa Figlia; Francesco Cuccia; Rosario Mazzola; Luca Nicosia; Francesco Ricchetti; Michele Rigo; Giorgio Attinà; Claudio Vitale; Gianluisa Sicignano; Antonio De Simone; Stefania Naccarato; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiat Oncol       Date:  2021-10-09       Impact factor: 3.481

3.  Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.

Authors:  Niccolò Giaj-Levra; Maximilian Niyazi; Vanessa Figlia; Giuseppe Napoli; Rosario Mazzola; Luca Nicosia; Stefanie Corradini; Ruggero Ruggieri; Giuseppe Minniti; Filippo Alongi
Journal:  Radiat Oncol       Date:  2019-10-26       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.